HER2 positive GC resection specimens are defined by ≥ 10% of tumor cells showing basolateral immunostaining intensity of 2 + and a confirmatory in situ hybridization showing HER2 amplification or a strong (3 +) basolateral immunostaining. Here, ERBB2 is linked to neoplasm.